Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0005930 | axoneme | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QHY8
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 67 | 69 | PF00675 | 0.549 |
CLV_PCSK_KEX2_1 | 67 | 69 | PF00082 | 0.567 |
CLV_PCSK_SKI1_1 | 148 | 152 | PF00082 | 0.463 |
CLV_PCSK_SKI1_1 | 169 | 173 | PF00082 | 0.395 |
CLV_PCSK_SKI1_1 | 47 | 51 | PF00082 | 0.535 |
DEG_SPOP_SBC_1 | 180 | 184 | PF00917 | 0.315 |
DOC_CDC14_PxL_1 | 150 | 158 | PF14671 | 0.315 |
DOC_CYCLIN_RxL_1 | 164 | 173 | PF00134 | 0.345 |
DOC_CYCLIN_RxL_1 | 44 | 54 | PF00134 | 0.513 |
DOC_MAPK_MEF2A_6 | 164 | 172 | PF00069 | 0.245 |
DOC_MAPK_MEF2A_6 | 195 | 204 | PF00069 | 0.294 |
DOC_PP4_FxxP_1 | 151 | 154 | PF00568 | 0.374 |
DOC_USP7_MATH_1 | 18 | 22 | PF00917 | 0.660 |
LIG_14-3-3_CanoR_1 | 124 | 132 | PF00244 | 0.405 |
LIG_14-3-3_CanoR_1 | 195 | 204 | PF00244 | 0.427 |
LIG_14-3-3_CanoR_1 | 22 | 31 | PF00244 | 0.555 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.677 |
LIG_eIF4E_1 | 197 | 203 | PF01652 | 0.345 |
LIG_EVH1_2 | 154 | 158 | PF00568 | 0.315 |
LIG_FHA_1 | 181 | 187 | PF00498 | 0.458 |
LIG_FHA_2 | 22 | 28 | PF00498 | 0.610 |
LIG_Pex14_2 | 145 | 149 | PF04695 | 0.539 |
LIG_Pex14_2 | 158 | 162 | PF04695 | 0.327 |
LIG_SH2_CRK | 197 | 201 | PF00017 | 0.315 |
LIG_SH2_STAP1 | 197 | 201 | PF00017 | 0.294 |
LIG_SH2_STAT3 | 191 | 194 | PF00017 | 0.345 |
LIG_SUMO_SIM_anti_2 | 198 | 206 | PF11976 | 0.294 |
LIG_SUMO_SIM_par_1 | 200 | 206 | PF11976 | 0.345 |
LIG_TRAF2_1 | 58 | 61 | PF00917 | 0.496 |
MOD_CK1_1 | 21 | 27 | PF00069 | 0.677 |
MOD_CK2_1 | 21 | 27 | PF00069 | 0.626 |
MOD_CK2_1 | 55 | 61 | PF00069 | 0.464 |
MOD_GlcNHglycan | 124 | 127 | PF01048 | 0.537 |
MOD_GlcNHglycan | 197 | 200 | PF01048 | 0.375 |
MOD_GlcNHglycan | 205 | 208 | PF01048 | 0.477 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.629 |
MOD_GSK3_1 | 18 | 25 | PF00069 | 0.671 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.660 |
MOD_NEK2_1 | 202 | 207 | PF00069 | 0.502 |
MOD_PKA_2 | 21 | 27 | PF00069 | 0.583 |
TRG_DiLeu_BaEn_1 | 166 | 171 | PF01217 | 0.245 |
TRG_DiLeu_BaEn_1 | 52 | 57 | PF01217 | 0.527 |
TRG_DiLeu_BaEn_4 | 60 | 66 | PF01217 | 0.473 |
TRG_DiLeu_LyEn_5 | 166 | 171 | PF01217 | 0.245 |
TRG_ENDOCYTIC_2 | 140 | 143 | PF00928 | 0.515 |
TRG_ENDOCYTIC_2 | 197 | 200 | PF00928 | 0.315 |
TRG_ER_diArg_1 | 67 | 69 | PF00400 | 0.549 |
TRG_Pf-PMV_PEXEL_1 | 169 | 173 | PF00026 | 0.345 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PCZ4 | Leptomonas seymouri | 54% | 88% |
A0A3S7WQK8 | Leishmania donovani | 95% | 100% |
A4H5L1 | Leishmania braziliensis | 78% | 100% |
A4HTV0 | Leishmania infantum | 95% | 100% |
E9AMN7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |